Universal Ibogaine (TSXV:IBO) 3-Year EBITDA Growth Rate : -26.00% (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine 3-Year EBITDA Growth Rate?

Universal Ibogaine's EBITDA per Share for the three months ended in Jan. 2024 was C$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -26.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Universal Ibogaine was 18.90% per year. The lowest was -98.80% per year. And the median was -26.00% per year.

Competitive Comparison of Universal Ibogaine's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Universal Ibogaine's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's 3-Year EBITDA Growth Rate falls into.

Universal Ibogaine 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Universal Ibogaine (TSXV:IBO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Universal Ibogaine 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines